A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System

NCT00475566 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis
Peripheral Vascular Disease

Interventions

DEVICE: Dynalink®-E everolimus-eluting peripheral stent
DEVICE: Dynalink®-E, everolimus-eluting peripheral stent

Sponsor

Abbott Medical Devices